The United States has authorized Pfizer Inc's antiviral COVID-19 pill for at-risk people aged 12 and above, making it the first oral treatment, and the first which can be taken at home, providing a potentially important tool in the fight against the fast-spreading Omicron variant.
Be the first to comment